SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Geronimo

PatientGeronimo
Date of birth1949-06-01
IdentifiersMRN HR-NI016-SYN; SSN (made up) 000-16-4729
Document date2026-09-23
AuthorRoberta Whitehorse-Lindgren, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Eleven-week review: therapy, sertraline, drinking and falls. [S]

History of Present Illness

Geronimo returns eleven weeks after intake, with the interpreter. He has had eight sessions of cognitive processing therapy; he missed one when he had bronchitis three weeks ago, which has cleared without antibiotics. He has taken sertraline 25 mg for five weeks without nausea or dizziness. The sodium test planned for two to four weeks after starting was not done: it was not ordered at the sick visit, and today's test is the first. Nightmares come about twice a week and he sleeps five or six hours. He takes a single drink on one or two evenings a week and has had no heavy evening since the last visit. He has not fallen. [S]

ElementDetail
TherapyEight of twelve sessions; one missed when ill
Sertraline25 mg for five weeks; no side effects
Sodium137 mmol/L
DrinkingOne drink on one or two evenings a week
PCL-535

Review of Systems

SystemResultFinding
PsychiatricPositiveNightmares about twice a week; mood lighter; no thoughts of suicide
RespiratoryNegativeCough gone
NeurologicalNegativeNo dizziness, confusion or headache
GastrointestinalNegativeNo nausea, bleeding or black stools

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-07-08activeS
Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicinesOne tablet dailyOral route2026-07-22activeS
Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium checkOne tablet each morningOral route2026-08-19 to 2026-09-23completedS
Sertraline 50 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-09-23activeS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for fever or aches, no more than 2,000 mg a day while his liver recoversOne or two tablets every 6 hours as needed, no more than 2,000 mg a dayOral route2026-09-02 to 2026-09-16completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-23Body height173cmS
2026-09-23Body weight67.2kgS
2026-09-23Body mass index (BMI) [Ratio]22.5kg/m2S
2026-09-23Systolic blood pressure130mm[Hg]S
2026-09-23Diastolic blood pressure78mm[Hg]S
2026-09-23Heart rate72/minS
2026-09-23Respiratory rate16/minS
2026-09-23Body temperature36.6CelS
2026-09-23Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-23PTSD PCL-5 score [PCL-5]35{score}S
2026-09-23Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-09-23Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-09-23Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma33U/L10-40 U/LNormalS
2026-09-23Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma27U/L7-56 U/LNormalS
2026-09-23Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma63U/L8-61 U/LHighS
2026-09-23Phosphatidylethanol [Mass/volume] in Blood41ng/mL<=20 ng/mLHighS

Physical Exam

Vital signs recorded on 2026-09-23; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 130/78 seated and 128/76 standing; pulse 72; weight 67.2 kg
Mental statusCalm and warm; speaks more of his horses and cattle; no thoughts of suicide or of harming anyone
GaitSteady; Timed Up and Go 12 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessedresolvedconfirmed G47.00S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep.
Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not metactiveconfirmed F43.12S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person.
Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinkingactiveconfirmed F10.20S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking.
A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 secondsactiveconfirmed Z91.81S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode.
Acute bronchitis with cough and low fever for six days, chest X-ray clear, oxygen saturation 95%; treated without antibiotics; resolvedresolvedconfirmed J20.9S — Synthetic self-limited illness; not a historical claim and not his documented last illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPTSD symptom severity (PCL-5)Baseline, then every visit during treatmentCompleted today35, from 56
Self-managementTrauma-focused psychotherapy (cognitive processing therapy), sessions attendedWeekly for twelve sessionsCompleted todayEight of twelve sessions; one missed during bronchitis
SurveyDepressive symptoms (PHQ-9)Baseline, then monthly during active treatmentCompleted today7, from 10; item 9 scored 0
SurveySuicide-risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; 988 card carried
Self-managementDrinking since the last visit, against his own goalEvery visitCompleted todayOne drink on one or two evenings a week; no heavy evening
LaboratoryLiver tests (AST, ALT, GGT) on naltrexoneBefore starting, at four to six weeks, then every three to six monthsCompleted todayAST 33, ALT 27, GGT 63 U/L
LaboratoryPEth, a blood marker of drinking over the past two to four weeksAt baseline and every one to three months during treatment, with consentCompleted today41 ng/mL, from 236
Medication safetyNaltrexone safety: opioid use, nausea, wallet cardEvery visitCompleted todayNo opioid use; he declined a codeine cough syrup during the bronchitis
Medication safetySSRI safety: sodium, bleeding, falls and side effectsSodium within the first month in older adults; review at each dose changeDeferredThe sodium check due two to four weeks after starting sertraline was missed: it was not ordered at the sick visit two weeks after the start, the one visit in that window. Done today at five weeks: 137 mmol/L, so no harm resulted, and he had no symptoms of low sodium. Corrective action: a laboratory-only visit is booked two weeks after any future SSRI dose change, and the clinic's SSRI order set now prompts the sodium check
Medication safetyPrazosin for nightmaresWhen nightmares persist despite first-line treatmentNot indicatedNightmares falling with therapy and sertraline; not needed now
ExaminationFalls and gait (Timed Up and Go), orthostatic blood pressureAt intake and every visit after a fallCompleted todayTimed Up and Go 12 seconds; standing pressure 128/76; no falls
Self-managementTraditional healing alongside clinic care, at his choiceEvery visitCompleted todayHis choice; nothing asked

Goal progress:

Guideline basis: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024)

Follow-up: Wellness visit in two weeks. Sixteen-week review in five weeks with PEth, liver tests, PCL-5, PHQ-9 and AUDIT. Call the clinic or 988 at any hour. Next scheduled visit 2026-10-07: initial annual wellness visit. [S]